InvestorsHub Logo

cowtown jay

11/03/21 6:18 PM

#34107 RE: The Other Guy #34106

Osolito shared a post here last week regarding the testing of fluvoxamine in Covid patients.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166543670

A psychiatrist who worked on the study noted, "Fluvoxamine may reduce the production of inflammatory molecules called cytokines, that can be triggered by SARS-CoV-2 infection," Reiersen said in a statement. The drug may also reduce blood platelets, which may affect the clotting effects of coronavirus infection."

https://www.cnn.com/2021/10/28/health/fluvoxamine-covid-risk-study/index.html

Fluvoxamine does not have the same clinical benefit to Covid patients that lenz has. But the drugs work the same way. Having a drug that could prevent encephalopathy and thrombosis could have been a game-changer for my wife, and I can't wait until doctors get to know lenz better, and it starts to be used in these indications.